HRSA-22-165: Rural Communities Opioid Response Program – Medication Assisted Treatment Access
Closed
This grant is closed. A newer notice from the same program is forecast: Rural Maternity and Obstetrics Management Strategies Program (HRSA-27-047). Status: Expected deadline April 20, 2027. It is in our archive of Health Resources and Services Administration notices from 2022.
Health Resources and Services Administration offered grants of up to $1.0 million to state and local governments, small businesses and businesses. It expected to make about 10 awards worth $10.0 million in total. Applications closed on July 29, 2022.
From the official notice on Grants.gov, last changed July 11, 2022. Checked November 7, 2026.
- Award ceiling$1.0 million
- Total funding$10.0 million
- Expected awards10
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | June 13, 2022 |
|---|---|
| Deadline | July 29, 2022 |
Who can apply
This opportunity was open to state and local governments, small businesses and businesses.
All 8 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants include all domestic public or private, non-profit and for-profit, entities. In addition to the 50 U.S. states, organizations in the District of Columbia, Guam, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, the U.S. Virgin Islands, the Federated State of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau may apply. Tribes and tribal organizations are eligible
Is this a realistic fit?
- Past Rural Healthcare Services Programs awards averaged $487,643; this notice allows up to $1.0 million per award.
- No cost sharing or match is required.
What the grant funds
The Rural Communities Opioid Response Program (RCORP) is a multi-year HRSA initiative aimed at reducing the morbidity and mortality of substance use disorder (SUD), including opioid use disorder (OUD), in rural communities. This notice announces the opportunity to apply for funding under the RCORP-Medication Assisted Treatment (MAT) Access Program. RCORP-MAT Access will advance RCORP’s overall goal by improving access to and quality of MAT and supportive services in rural communities. The purpose of this program is to improve health care in rural areas by establishing new MAT access points and increasing the capacity for sustainable MAT service provision in rural areas. This program is intended to support MAT to treat OUD, however HRSA encourages award recipients to also target alcohol use disorder (AUD) with MAT if the need exists. Over the course of the three-year period of performance, RCORP-MAT Access recipients will implement activities that are aligned with the following overarching program goals: Goal 1 - Establish new MAT access points to provide both medications and supportive services to individuals with OUD and/or AUD in rural communities; Goal 2 - Enhance the MAT workforce through recruitment, training, and the development of peer mentorship networks; Goal 3 - Build community capacity and infrastructure to support more effective and efficient MAT service provision; and, Goal 4 - Ensure sustainability of the new MAT access points through improved billing and coding, as well as enrollment of eligible individuals into health insurance. For the purposes of this NOFO, “MAT access” includes affordability, accessibility, acceptability, and availability of MAT treatment and supportive services for rural individuals who reside in the rural areas as defined by the Rural Health Grants Eligibility Analyzer. Additionally, HRSA defines MAT as the use of U.S. Food and Drug Administration (FDA)-approved medications, in combination with counseling and behavioral therapies, to provide a “whole-person” approach to the treatment of substance use disorders, including opioid use disorder and alcohol use disorder (AUD).
Who has won Rural Healthcare Services Programs grants before
From fiscal 2021 to 2025, Rural Healthcare Services Programs (93.912) awarded $727 million across 1,490 grant awards, an average of $487,643 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Rural Health Resource Center | Minnesota | 3 | $58.6 million |
| University of North Dakota | North Dakota | 3 | $10.3 million |
| JBS International, Inc. | Maryland | 1 | $10.1 million |
| Arkansas Rural Health Partnership | Arkansas | 6 | $8.3 million |
| Rural Health Redesign Center Organization, Inc. | Pennsylvania | 3 | $7.9 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-047, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-22-165 still open?
No. It closed on July 29, 2022. A newer notice is forecast: HRSA-27-047, expected deadline April 20, 2027.
Who can apply for Rural Communities Opioid Response Program – Medication Assisted Treatment Access?
Health Resources and Services Administration accepted applications from state and local governments, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Rural Communities Opioid Response Program – Medication Assisted Treatment Access?
Closed July 29, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.0 million each. About $10.0 million in total across about 10 awards.
Who has won Rural Healthcare Services Programs grants before?
The largest recipients over five fiscal years were Rural Health Resource Center, University of North Dakota, JBS International, Inc. The program made 1,490 awards worth $727 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)